Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

ClinicalTrials.gov ID: NCT00943072

Public ClinicalTrials.gov record NCT00943072. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 8:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double Masked, Controlled Phase 3 Study of the Efficacy, Safety, and Tolerability of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor Trap-Eye in Subjects With Macular Edema Secondary to Central Retinal Vein Occlusion

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 3 study to determine the efficacy of VEGF Trap-Eye injected into the eye on vision function in subjects with macular edema as a consequence of central retinal vein occlusion.

Study identification

NCT ID
NCT00943072
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Regeneron Pharmaceuticals
Industry
Enrollment
189 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2009 (Type not available)
Primary completion
Oct 2010 (Actual)
Completion
Apr 2012 (Actual)
Last update posted
May 27, 2013

2009 – 2012

United States locations

U.S. sites
46
U.S. states
23
U.S. cities
44
Facility City State ZIP Site status
Not listed Phoenix Arizona 85014 —
Not listed Phoenix Arizona 85020 —
Not listed Tucson Arizona 85704 —
Not listed Arcadia California 91007 —
Not listed Beverly Hills California 90211 —
Not listed La Jolla California 92037 —
Not listed Mountain View California 94040 —
Not listed Oakland California 94609 —
Not listed Sacramento California 95841 —
Not listed Torrance California 90503 —
Not listed New London Connecticut 06320 —
Not listed Altamonte Springs Florida 32701 —
Not listed Fort Lauderdale Florida 33334 —
Not listed Fort Myers Florida 33907 —
Not listed Fort Myers Florida 33912 —
Not listed Miami Florida 33143 —
Not listed Palm Beach Gardens Florida 33410 —
Not listed Winter Haven Florida 33880 —
Not listed Augusta Georgia 30909 —
Not listed Chicago Illinois 60612 —
Not listed Wichita Kansas 67214 —
Not listed Baltimore Maryland 21209 —
Not listed Hagerstown Maryland 21740 —
Not listed Towson Maryland 21204 —
Not listed Boston Massachusetts 02114 —
Not listed Grand Rapids Michigan 49525 —
Not listed Jackson Michigan 48104 —
Not listed Lincoln Nebraska 68506 —
Not listed Las Vegas Nevada 89135 —
Not listed Northfield New Jersey 08225 —
Not listed Toms River New Jersey 08755 —
Not listed Rochester New York 14620 —
Not listed Winston-Salem North Carolina 27157 —
Not listed Cleveland Ohio 44195 —
Not listed Oklahoma City Oklahoma 73104 —
Not listed Portland Oregon 97210 —
Not listed Salem Oregon 97302 —
Not listed Kingston Pennsylvania 18704 —
Not listed Pittsburgh Pennsylvania 15213 —
Not listed West Columbia South Carolina 29169 —
Not listed Rapid City South Dakota 57701 —
Not listed Nashville Tennessee 37203 —
Not listed Abilene Texas 79606 —
Not listed Fort Worth Texas 76102 —
Not listed Houston Texas 77030 —
Not listed San Antonio Texas 78240 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00943072, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 27, 2013 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00943072 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →